Patent · US Active

Antigen associated with the neovasculature of tumour metastases

US9896503B2 · kind B2 · utility

2Cited by
7References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 5, 2015
Grant dateFeb 20, 2018
Priority date
Expiry dateApr 6, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a binding member that binds the Extra Domain-A (ED-A) isoform of fibronectin for the treatment of tumour metastases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.